We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+14.08%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$1.84B
AUM Growth
+$183M
Cap. Flow
+$14.5M
Cap. Flow %
0.79%
Top 10 Hldgs %
24.03%
Holding
217
New
10
Increased
110
Reduced
71
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 33.15%
2 Healthcare 20.69%
3 Industrials 16.11%
4 Consumer Discretionary 8.96%
5 Consumer Staples 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLNT
176
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$1.25M 0.07%
63,312
+2,474
+4% +$62.5K
SOHO
177
DELISTED
Sotherly Hotels
SOHO
$1.21M 0.07%
168,466
-671
-0.4% -$4.79K
LYV icon
178
Live Nation Entertainment
LYV
$42.1B
$1.15M 0.06%
21,175
+5,846
+38% +$296K
NVTR
179
DELISTED
Nuvectra Corporation Common Stock
NVTR
$1.12M 0.06%
+51,100
New +$983K
SUPN icon
180
Supernus Pharmaceuticals
SUPN
$2.77B
$973K 0.05%
19,321
-7,068
-27% -$349K
FLGT icon
181
Fulgent Genetics
FLGT
$527M
$894K 0.05%
227,509
+276
+0.1% +$1.18K
JNCE
182
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$879K 0.05%
135,280
+3,688
+3% +$27.4K
ANGI icon
183
Angi Inc
ANGI
$196M
$704K 0.04%
2,997
+1,686
+129% +$325K
NBRV
184
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$668K 0.04%
+989
New +$701K
FBRX icon
185
Forte Biosciences
FBRX
$1.57B
$662K 0.04%
113
MTCH icon
186
Match Group
MTCH
$8.55B
$653K 0.04%
11,269
+3,103
+38% +$145K
AVEO
187
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$595K 0.03%
17,985
+34
+0.2% +$874
AKAO
188
DELISTED
Achaogen Inc
AKAO
$585K 0.03%
146,588
+5,727
+4% +$34.6K
GHDX
189
DELISTED
Genomic Health, Inc.
GHDX
$463K 0.03%
+6,600
New +$386K
EPAY
190
DELISTED
Bottomline Technologies Inc
EPAY
$320K 0.02%
4,400
CVGW
191
DELISTED
Calavo Growers
CVGW
$306K 0.02%
3,169
-118,619
-97% -$11.7M
HAE icon
192
Haemonetics
HAE
$4B
$292K 0.02%
2,550
VYNT
193
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$289K 0.02%
1,855
+12
+0.7% +$1.78K
BCPC
194
Balchem Corp
BCPC
$5.72B
$256K 0.01%
2,285
NEOG icon
195
Neogen
NEOG
$2.5B
$253K 0.01%
7,066
HQY icon
196
HealthEquity
HQY
$8.75B
$244K 0.01%
+2,580
New +$222K
PEGA icon
197
Pegasystems
PEGA
$5.38B
$236K 0.01%
7,540
FCFS icon
198
FirstCash
FCFS
$8.78B
$230K 0.01%
2,810
IONS icon
199
Ionis Pharmaceuticals
IONS
$9.4B
$223K 0.01%
+4,316
New +$203K
KA
200
DELISTED
Kineta, Inc. Common Stock
KA
$197K 0.01%
585
+1
+0.2% +$357

Similar funds

Granahan Investment Management's Q3 2018 Portfolio in Review

As of Q3 2018, Granahan Investment Management held 217 positions worth $1.84B, up 11% from $1.66B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Granahan Investment Management's Q3 2018 filing shows 10 new, 110 increased, 71 reduced and 16 closed positions. Its largest new stake was Etsy: 542,972 shares worth $27.9M. The largest sale was SodaStream International Ltd, an estimated $35.1M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

  • Granahan Investment Management's largest Q3 2018 buy was Etsy: 542,972 shares worth $27.9M.
  • Granahan Investment Management added most to Strategic Education in Q3 2018, an estimated $16.2M increase.
  • Granahan Investment Management's biggest Q3 2018 reduction was SodaStream International Ltd, cutting an estimated $35.1M.
  • Granahan Investment Management fully exited CARE.COM, INC. in Q3 2018, selling an estimated $8.96M.
  • Granahan Investment Management's ten largest holdings make up 24% of its $1.84B portfolio in Q3 2018.
  • Granahan Investment Management opened 10 new positions and closed 16 in Q3 2018.
  • Granahan Investment Management's portfolio value rose 11% quarter-over-quarter to $1.84B.

Based on Granahan Investment Management's 13F filing for Q3 2018, filed 13 Nov 2018.